42c earnings would make it hard to see us under $2.00 SP at that stage. Other price kickers will be the new drugs and areas brought into the company’s portfolio over the next 12 months or so, as it seems easy/quicker to make them compared with the trial timelines. And all the while BigPharma is watching on and potentially they will like our platform and partner with us giving PYC a chunk of money and milestone payments.This could happen anytime in my view. This company will look very different in 2 years due to these potential extras, so.... 50c is doable within the next 2 years without any revenue. And remember, each time PYC adds a new drug it will have been selected for its potential revenue prospects as much as its use to society. I think this company will stay in my portfolio as its SP trajectory could be like CSL’s. ($2.40 to $900)
PYC Price at posting:
17.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)